Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Clinical Trial
Official title:
Development of Pediatric Acute Myeloid Leukemia Xenograft Models for the Testing of Targeted Therapeutic Agents
These laboratory trial studies the development and treatment of a mouse model for acute myeloid leukemia (AML) using samples from younger patients with AML. Studying tissue samples from patients with cancer in the laboratory may help doctors learn more about cancer and how well patients will respond to treatment.
PRIMARY OBJECTIVES:
I. To determine the rate of engraftment of pediatric FMS-Like Tyrosine Kinase-3
(FLT3)-internal tandem duplication (ITD) acute myeloid leukemia (AML) samples in NOD scid
gamma (NSG) mice.
II. To determine the efficacy of treatment of FLT3-ITD xenografts with tyrosine kinase
inhibitors.
OUTLINE:
Human acute myeloid leukemia cells are injected into NSG mice. Mice are then treated with
sorafenib or quizartinib via gavage once daily for 28 days. Peripheral blood and tissue
samples are collected biweekly or weekly and analyzed for the presence of human CD45+ and
CD33+ cells by quantitative flow cytometry.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01492569 -
Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting
|
N/A | |
Completed |
NCT01642069 -
Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia
|
N/A | |
Completed |
NCT01150669 -
Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia
|
N/A | |
Completed |
NCT01642121 -
Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia
|
N/A |